Provided by Tiger Trade Technology Pte. Ltd.

OneStream, Inc.

23.98
+0.15000.63%
Post-market: 23.980.0001+0.00%19:25 EDT
Volume:10.63M
Turnover:254.83M
Market Cap:4.56B
PE:-85.64
High:24.04
Open:23.80
Low:23.77
Close:23.83
52wk High:29.66
52wk Low:16.51
Shares:190.00M
Float Shares:84.67M
Volume Ratio:9.22
T/O Rate:12.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2800
EPS(LYR):-0.2800
ROE:-12.41%
ROA:-6.41%
PB:9.03
PE(LYR):-85.64

Loading ...

InnoCare’s next-generation TRKi Zurletrectinib Receives Priority Review for the Treatment of Pediatric Patients with Solid Tumors in China

GlobeNewswire
·
Mar 02

OneStream Agrees to $24-Per-Share Buyout by Hg

Reuters
·
Mar 02

Press Release: ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Dow Jones
·
Feb 28

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Feb 27

BTIG Downgrades Onestream to Neutral From Buy

MT Newswires Live
·
Feb 27

Onestream Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
Feb 27

OneStream Cut to Neutral From Buy by BTIG

Dow Jones
·
Feb 27

OneStream posts Q4 subscription revenue of USD 150.3 million, up 27%

Reuters
·
Feb 27

OneStream Q4 Adj. EPS $0.12 Beats $0.05 Estimate, Sales $163.732M Beat $157.282M Estimate

Benzinga
·
Feb 27

Onestream Inc - Q4 Total Revenue $163.7 Mln

THOMSON REUTERS
·
Feb 27

Onestream Inc Q4 Adj EPS $0.12

THOMSON REUTERS
·
Feb 27

Press Release: Immunocore reports fourth quarter and full year 2025 financial results and provides a business update

Dow Jones
·
Feb 25

Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

prnewswire
·
Feb 25

LiveOne app now available on VIZIO Smart TVs

TIPRANKS
·
Feb 23

OneStream Agrees to $24-Per-Share Acquisition by Hg

Reuters
·
Feb 20

OneStream Chief Revenue Officer Ken Hohenstein Disposes of Common Shares

Reuters
·
Feb 20

Earning Preview: OneStream, Inc. revenue is expected to increase by 22.73%, and institutional views are predominantly bullish

Earnings Agent
·
Feb 19

Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors

GlobeNewswire
·
Feb 18

NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer

GlobeNewswire
·
Feb 18

OneStream Inc. Files Draft Information Statement on Merger Authorization

Reuters
·
Feb 17